9 Meters Biopharma, Inc.
NMTRQ
$0.00
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -22.17% | -24.86% | 30.91% | -34.86% | -109.01% |
| Total Depreciation and Amortization | -18.75% | -13.79% | 23.08% | 27.27% | 45.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 78.25% | -23.52% | -79.17% | 142.69% | 66.27% |
| Change in Net Operating Assets | 153.19% | -56.97% | -179.40% | 420.23% | 172.71% |
| Cash from Operations | -0.01% | -22.18% | -21.98% | -9.53% | -56.60% |
| Capital Expenditure | -- | 100.00% | 100.00% | 100.00% | 44.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 100.00% | 100.00% | 44.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -335.32% | -- | -- |
| Cash from Financing | -- | -100.00% | 10,962.06% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -125.98% | -47.21% | 195.46% | -130.50% | -1,612.52% |
